Premium
Brentuximab induced CD 30 + cutaneous lymphoma responded to anti‐ PD 1 treatment
Author(s) -
Nikolaou V.,
Iliakis T.,
Marinos L.,
Economidi A.,
Panayiotidis P.,
Rigopoulos D.,
Stratigos AJ
Publication year - 2019
Publication title -
journal of the european academy of dermatology and venereology
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 1.655
H-Index - 107
eISSN - 1468-3083
pISSN - 0926-9959
DOI - 10.1111/jdv.15378
Subject(s) - medicine , cutaneous lymphoma , dermatology , mycosis fungoides , lymphoma , medical school , family medicine , general hospital , cutaneous t cell lymphoma , university hospital , medical education